Argenx to highlight key programs from neuromuscular franchise at upcoming medical meetings

Scientific presentations demonstrate argenx's leadership in fcrn blockade and commitment to innovati ng for patients across multiple neuromuscular diseases

ARGX Ratings Summary

ARGX Quant Ranking